73 related articles for article (PubMed ID: 8327371)
1. [Levels of beta-endorphin in serum of patients with chronic renal failure treated with hemodialysis during a test which stimulates hypoglycemia after insulin].
Trelewicz P; Grzeszczak W; Drabczyk R
Pol Arch Med Wewn; 1993 Mar; 89(3):217-22. PubMed ID: 8327371
[TBL] [Abstract][Full Text] [Related]
2. [Levels of beta-endorphin in serum of patients with chronic renal failure on conservative treatment during insulin-induced hypoglycemia stimulation testing].
Trelewicz P; Drabczyk R; Grzeszczak W
Przegl Lek; 1992; 49(11):372-4. PubMed ID: 1306570
[TBL] [Abstract][Full Text] [Related]
3. [The effect of hemodialysis on levels of beta-endorphin in serum of patients with chronic renal failure treated with erythropoietin].
Burak W; Grzeszczak W; Trelewicz P; Zukowska-Szczechowska E
Przegl Lek; 1996; 53(2):54-7. PubMed ID: 8754321
[TBL] [Abstract][Full Text] [Related]
4. Serum beta-endorphin in non-dialysed and haemodialysed patients with chronic renal failure.
Trelewicz P; Grzeszczak W; Drabczyk R
Int Urol Nephrol; 1994; 26(1):117-23. PubMed ID: 8026916
[TBL] [Abstract][Full Text] [Related]
5. Plasma beta-endorphin levels and glucose tolerance in patients with chronic renal failure.
Barreca T; Robaudo C; Cataldi A; Garibaldi A; Cianciosi P; Russo R; Rolandi E; Franceschini R
Biomed Pharmacother; 1995; 49(6):283-7. PubMed ID: 7579009
[TBL] [Abstract][Full Text] [Related]
6. Influence of recombinant human erythropoietin treatment on cortisol responses to insulin-induced hypoglycemia in CAPD patients.
Díez JJ; Iglesias P; Sastre J; Gómez-Pan A; Selgas R; Romero JR; Méndez J
Adv Perit Dial; 1993; 9():336-41. PubMed ID: 8105958
[TBL] [Abstract][Full Text] [Related]
7. Substantial rise of plasma beta-endorphin levels after insulin-induced hypoglycemia in human subjects.
Nakao K; Nakai Y; Jingami H; Oki S; Fukata J; Imura H
J Clin Endocrinol Metab; 1979 Dec; 49(6):838-41. PubMed ID: 229118
[TBL] [Abstract][Full Text] [Related]
8. Resistin serum levels are increased but not correlated with insulin resistance in chronic hemodialysis patients.
Filippidis G; Liakopoulos V; Mertens PR; Kiropoulos T; Stakias N; Verikouki C; Patsidis E; Koukoulis G; Stefanidis I
Blood Purif; 2005; 23(6):421-8. PubMed ID: 16141714
[TBL] [Abstract][Full Text] [Related]
9. Beta-endorphin inhibits hypoglycemia-induced gene expression of corticotropin-releasing factor in the rat hypothalamus.
Suda T; Sato Y; Sumitomo T; Nakano Y; Tozawa F; Iwai I; Yamada M; Demura H
Endocrinology; 1992 Mar; 130(3):1325-30. PubMed ID: 1311237
[TBL] [Abstract][Full Text] [Related]
10. Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal humans: low dose, standard high dose, and 8-hour ACTH-(1-24) infusion tests.
Nye EJ; Grice JE; Hockings GI; Strakosch CR; Crosbie GV; Walters MM; Jackson RV
J Clin Endocrinol Metab; 1999 Oct; 84(10):3648-55. PubMed ID: 10523009
[TBL] [Abstract][Full Text] [Related]
11. Beta-lipotropin/adrenocorticotropic hormone responses to corticotropin releasing hormone, hypoglycemia, metyrapone and dexamethasone in normal human subjects.
Castro M; Moreira AC
Braz J Med Biol Res; 1990; 23(11):1107-15. PubMed ID: 1966779
[TBL] [Abstract][Full Text] [Related]
12. [Plasma beta-endorphin in patients on maintenance hemodialysis].
Yamakado M; Tagawa H; Kiyose H; Kotsugai N; Sato K; Takatori O
Nihon Jinzo Gakkai Shi; 1989 Sep; 31(9):963-7. PubMed ID: 2531244
[TBL] [Abstract][Full Text] [Related]
13. Increase of beta-endorphin serum levels by human corticotropin-releasing factor does not affect beta-cell function in normal-weight men.
Ritter MM; Richter WO; Schwandt P
Horm Metab Res; 1989 Jul; 21(7):383-6. PubMed ID: 2528500
[TBL] [Abstract][Full Text] [Related]
14. Corticotropin-releasing hormone reduces pressure pain sensitivity in humans without involvement of beta-endorphin(1-31), but does not reduce heat pain sensitivity.
Matejec R; Uhlich H; Hotz C; Mühling J; Harbach HW; Bödeker RH; Hempelmann G; Teschemacher H
Neuroendocrinology; 2005; 82(3-4):185-97. PubMed ID: 16534240
[TBL] [Abstract][Full Text] [Related]
15. [Insulin resistance in the uremic patient: effects of hemodialysis].
Sechi LA; Melis A; Pala A; Orecchioni C; Tedde R
Boll Soc Ital Biol Sper; 1990 Oct; 66(10):993-9. PubMed ID: 2096883
[TBL] [Abstract][Full Text] [Related]
16. Role of parathyroid hormone in the glucose intolerance of chronic renal failure.
Akmal M; Massry SG; Goldstein DA; Fanti P; Weisz A; DeFronzo RA
J Clin Invest; 1985 Mar; 75(3):1037-44. PubMed ID: 3884663
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic actions of corticotropin-releasing hormone and proopiomelanocortin derivatives in septic patients.
Matejec R; Löcke G; Kayser F; Lichtenstern C; Weigand MA; Welters ID; Bödeker RH; Harbach HW
J Cardiovasc Pharmacol; 2011 Jan; 57(1):94-102. PubMed ID: 20980919
[TBL] [Abstract][Full Text] [Related]
18. Effect of ovine corticotropin-releasing hormone administered during insulin-induced hypoglycemia on plasma adrenocorticotropin and cortisol.
DeCherney GS; DeBold CR; Jackson RV; Sheldon WR; Kamilaris TC; Island DP; Orth DN
J Clin Endocrinol Metab; 1987 Jun; 64(6):1211-8. PubMed ID: 3033009
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of adrenocorticotropin secretion by insulin-induced hypoglycemia in the developing rat involves arginine vasopressin but not corticotropin-releasing factor.
Muret L; Priou A; Oliver C; Grino M
Endocrinology; 1992 May; 130(5):2725-32. PubMed ID: 1315256
[TBL] [Abstract][Full Text] [Related]
20. [Effect of naloxone on beta-endorphin and insulin concentrations during glucose tolerance testing in patients with simple obesity].
Krzyzanowska-Swiniarska B; Gruszczyńska M; Pilarska K; Widecka K; Czekalski S
Endokrynol Pol; 1993; 44(4):517-29. PubMed ID: 8055820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
